editorial | Q871232 |
review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1017/S1121189X00004711 |
P698 | PubMed publication ID | 17619540 |
P2093 | author name string | Paola Salvatore | |
Leonardo Tondo | |||
Mauricio Tohen | |||
Christopher Baethge | |||
Ross J Baldessarini | |||
Hari-Mandir Kaur Khalsa | |||
P2860 | cites work | Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up | Q80440820 |
Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials | Q73963103 | ||
Twelve-month outcome after a first hospitalization for affective psychosis | Q74066227 | ||
12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode | Q74541226 | ||
A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders | Q76400299 | ||
Recurrence of bipolar disorders and major depression. A life-long perspective | Q79077975 | ||
Remission in first-episode psychosis: predictor variables and symptom improvement patterns | Q79463287 | ||
Long-term clinical course of patients with acute polymorphic psychotic disorder without symptoms of schizophrenia | Q80048798 | ||
The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence | Q22241870 | ||
Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals | Q22251461 | ||
Specificity of developmental precursors to schizophrenia and affective disorders | Q33744345 | ||
Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
Diagnosing schizophrenia in the initial prodromal phase | Q33933362 | ||
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders | Q34106678 | ||
Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study | Q34340583 | ||
Comparative efficacy and tolerability of drug treatments for bipolar disorder | Q34387550 | ||
On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary | Q34543895 | ||
Is lithium still worth using? An update of selected recent research | Q34565672 | ||
Suicidal behaviour in bipolar disorder: risk and prevention | Q35129379 | ||
Rapid-cycling bipolar disorder: effects of long-term treatments | Q35154713 | ||
Prophylaxis latency and outcome in bipolar disorders | Q35217473 | ||
Pretreatment Episode Count and Response to Lithium Treatment in Manic-Depressive Illness | Q35557752 | ||
Antidepressants in bipolar disorder: the case for caution | Q35592492 | ||
Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. | Q36093549 | ||
The Natural Course of Schizophrenia: A Review of First-admission Studies | Q36279547 | ||
Outcomes to monitor when treating bipolar disorder or schizophrenia. | Q36654310 | ||
Bipolar depression: a review of randomised clinical trials | Q36681303 | ||
Measurable outcomes in psychiatric disorders: remission as a marker of wellness | Q36703208 | ||
A polyepisodic course in bipolar illness: possible clinical relationships | Q38491028 | ||
Course and outcome of acute non-organic psychotic states in India. | Q39431178 | ||
Major affective disorder as a recurrent illness: a critical review | Q39912450 | ||
Comparison of cognitive functions between first- and multi-episode bipolar affective disorders | Q40327664 | ||
Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia? | Q40771364 | ||
Lifelong development of risk of recurrence in depressive disorders | Q40920073 | ||
The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group | Q41817618 | ||
Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. | Q42164355 | ||
Recovery and functional outcomes following olanzapine treatment for bipolar I mania | Q42645283 | ||
Relapse and impairment in bipolar disorder | Q43514252 | ||
15-year outcome of treated bipolar disorder | Q43540831 | ||
Substance abuse in first-episode bipolar I disorder: indications for early intervention | Q43702427 | ||
Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival | Q44047289 | ||
Further investigation of the predictors of outcome following first schizophrenic episodes | Q44065262 | ||
The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome | Q44276631 | ||
Antidepressant treatment in bipolar versus unipolar depression | Q44710957 | ||
Bipolar patients with suicidal behavior: toward the identification of a clinical subgroup. | Q45026407 | ||
Life events and schizophrenic relapse after withdrawal of medication | Q45979354 | ||
Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates. | Q46178019 | ||
The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
The initial prodrome to bipolar affective disorder: prospective case studies | Q47450065 | ||
Time course and biologic correlates of treatment response in first-episode schizophrenia | Q48298764 | ||
A comparison of DSM-IV brief psychotic disorder with "positive" schizophrenia and healthy controls | Q48622916 | ||
Psychopathology factors in first-episode affective and non-affective psychotic disorders. | Q50303631 | ||
Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. | Q50475369 | ||
The enduring psychosocial consequences of mania and depression. | Q50608957 | ||
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. | Q50656709 | ||
Recurrence in affective disorder. I. Case register study. | Q50897602 | ||
Course of adolescent psychotic disorder with schizoaffective episodes. | Q50960850 | ||
Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. | Q51917536 | ||
Diagnostic stability 18 months after treatment initiation for first-episode psychosis. | Q51924630 | ||
Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis. | Q51937861 | ||
Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population. | Q51940592 | ||
Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department. | Q51967201 | ||
Long-term prognosis of bipolar I disorder. | Q51986583 | ||
The dimensional structure of first episode psychosis: an exploratory factor analysis. | Q51991652 | ||
The Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients. | Q52003927 | ||
The Suffolk County Mental Health Project: demographic, pre-morbid and clinical correlates of 6-month outcome. | Q52007862 | ||
The likelihood of recurrence in bipolar affective disorder: the importance of episode recency. | Q52017623 | ||
Developmental precursors of child- and adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. | Q52025358 | ||
Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. | Q52028648 | ||
Complicated mania. Comorbidity and immediate outcome in the treatment of mania. | Q52071062 | ||
The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. | Q52074583 | ||
Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study. | Q52080357 | ||
Phenomenology and outcome of subjects with early- and adult-onset psychotic mania. | Q52893207 | ||
The epidemiology of DSM-III-R bipolar I disorder in a general population survey. | Q53357821 | ||
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. | Q54445897 | ||
Diagnosis, Treatment, and Six-Month Outcome Status in First-Admission Psychosis | Q58300516 | ||
Bipolar I: A Five-Year Prospective Follow-up | Q60447096 | ||
Outcome of patients with chronic affective disorder: a five-year follow- up | Q60447111 | ||
Differential Outcome of Pure Manic, Mixed/Cycling, and Pure Depressive Episodes in Patients With Bipolar Illness | Q60447147 | ||
The McLean–Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis | Q60643065 | ||
Recurrence in Affective Disorder: Analyses with Frailty Models | Q60643576 | ||
Outcome in manic disorders. A naturalistic follow-up study | Q67301345 | ||
Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features | Q67567375 | ||
Refining the diagnosis of schizophreniform disorder | Q68358111 | ||
Four-year follow-up of twenty-four first-episode manic patients | Q68423068 | ||
Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis | Q68610336 | ||
Measurement of social disability in a schizophrenic patient group. Definition, assessment and outcome over 2 years in a cohort of schizophrenic patients of recent onset | Q69501003 | ||
The role of social relationships in the course of first-episode schizophrenia and affective psychosis | Q69801736 | ||
Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period | Q70785290 | ||
Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder | Q71196515 | ||
Negative symptoms in the course of first-episode affective psychosis | Q72040937 | ||
Outcome and comorbidity in first- compared with multiple-episode mania | Q72224625 | ||
Course and outcome in bipolar affective disorder: a longitudinal follow-up study | Q72565096 | ||
Fluphenazine vs Placebo in Patients With Remitted, Acute First-Episode Schizophrenia | Q72919729 | ||
Prodromal states in schizophrenia | Q73622818 | ||
Maintenance treatment in bipolar disorder | Q73782425 | ||
Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders | Q73963098 | ||
P433 | issue | 2 | |
P921 | main subject | longitudinal research | Q124138857 |
P304 | page(s) | 109-117 | |
P577 | publication date | 2007-04-01 | |
P1433 | published in | Epidemiologia e Psichiatria Sociale | Q15761581 |
P1476 | title | Longitudinal research on bipolar disorders | |
P478 | volume | 16 |
Q37478023 | Recurrence in Patients with Bipolar Disorder and Its Risk Factors |
Q43920622 | Achieving a better knowledge on the causes and early course of psychoses: a profitable investment for the future? |
Q42702891 | Animal models for bipolar disorder: from bedside to the cage. |
Q36902087 | Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells. |
Q43704138 | Evaluation of Bipolar Disorder in Several Relapses over Time Using Generalized Estimating Equations |
Q30496309 | Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. |
Q48445495 | Laterality effects in schizophrenia and bipolar disorder |
Q34730291 | Relating the bipolar spectrum to dysregulation of behavioural activation: a perspective from dynamical modelling |
Q36674096 | Ten-year diagnostic consistency of bipolar disorder in a first-admission sample |